Biophotonics Market Size
The global Biophotonics Market was valued at USD 78.17 billion in 2025 and is projected to reach USD 165.86 billion by 2033, growing at a CAGR of 9.86% from 2026 to 2033.
Biophotonics Market Summary and Scope
Metrics | Details |
Market CAGR | 9.86% |
Segments Covered | By Technology, By Application, By End User, and By Region |
Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region | Asia Pacific |
Largest Market Share | North America |
Biophotonics Market Dynamics and Trends
The global bioPhotonics market growth is driven by the growing geriatric population, increasing use of biophotonics in cell and tissue diagnostics, the emergence of nanotechnology in biophotonics and development of Novel Photoacoustic Tomography (PAT) System.
The emergence of nanotechnology in biophotonics is expected to drive the growth in the forecast period
Research in biology has shifted from the cell level to viruses and cellular constituents, such as proteins and nucleic acids. Tools for investigating these constituents must operate on the same scale, shifting focus from micro-scale to nano-scale. As a result, nanotechnology’s applications in imaging biological processes for analyzing biological materials have increased. Gold and iron nanoparticles are used in biomedical imaging; for instance, the gold nanoparticle is used by researchers from the University of Rochester on the tip of an optical fiber as an antenna to enhance the fluorescence of labeled proteins in the cell membrane. Gold nanoparticles are also used along with a laser to destroy cancer cells. In comparison, silica nanoparticles are less toxic than gold nanoparticles and can be targeted against specific pathogens or tumors.
These nanoparticles can also carry chemotherapy drugs directly to tumors, reducing the harmful effects of these drugs on the body. The increasing benefits of biophotonics, concerning nanotechnology through improved artificial markers, are expected to drive the market.
Few disadvantages of this method are likely to hamper the market growth
The disadvantage of this method is that it only captures the intensity information of the fluorescence signals. Therefore, this approach is sensitive to the fluctuations of the excitation light, distance of the probe from the tumor, and parameters of the system.
Biophotonics Market Segmentation Analysis
The inside imaging segment is expected to hold the largest share in this market segment
Inside Imaging (Endoscopy) is expected to hold the largest share in the forecast period. The integration of detection, characterization, diagnosis, and staging during endoscopy is still an unmet medical need. The beginning of biophotonics in endoscopy has unlocked new prospects and created some significant and new opportunities for the enhanced identification and biochemical characterization of diseases. The most appropriate and useful method for categorizing biophotonic endoscopic techniques can be their ability to provide functional and biochemical information and enhance spatial resolution. SHG (Second Harmonic Generation), fa/LCI (frequency-domain angle-resolved low coherence interferometry), and near-IR (near-infrared) technologies are some of the commonly used visualization technologies. One of the most useful applications of biophotonics in medicine is photodynamic therapy. The treatment is used for cancer but can also be used on acne and psoriasis. Such application of these technologies drives the demand for the biophotonics market.
Biophotonics Market Geographical Share
North America region holds the largest market share of global biophotonics market
North America currently dominates the market for BioPhotonics and is expected to continue its stronghold for a few more years. The United States is a major market in the biophotonics industry, mainly owing to the United States government’s initiatives to develop the industry. In addition, the emergence of nanotechnology has driven the biophotonics market in the United States.
Jenoptik Light and Optics Biophotonics group recently won several new development orders in North America. The first order is for the design of the camera system for a next-generation fiber-optic medical device to be used in a robotic surgical instrument. The second development project is to design multiple subassemblies for a Tier 1 eye care company’s next-generation ophthalmology surgery system. For the third program, Jenoptik is teaming with a major worldwide supplier of medical laboratory equipment to supply a next-generation automated microscope for inline cellular analysis. The fourth project is a long-standing partnership with a medical diagnostics company specializing in real-time point of care (POC) serology tests. These initiatives may fuel the growth of the BioPhotonics market over the forecast period in North America.
Biophotonics Companies and Competitive Landscape
The global biophotonics market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Thermofisher Scientific, Becton, Dickinson and Company, Hamamatsu Photonics KK, Olympus Corporation, Carl Zeiss AG, and PerkinElmer Inc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market. The new site will incorporate the X-Ray Microscopy business along with the ZEISS Microscopy Customer Center to provide support for the opportunities in materials research, life sciences and industrial applications.
Global BioPhotonics Market – Key Companies to Watch
Thermofisher Scientific
Overview: Thermo Fisher Scientific is global manufacturer and provider of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry. The company delivers a combination of innovative technologies, purchasing convenience and pharmaceutical services through various industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
Product Portfolio: It includes DXR3 Raman Microscope, DXR3xi Raman Imaging Microscope, DXR3 SmartRaman Spectrometer.
Recent Development-
- February 2026: Carl Zeiss AG advanced its biophotonics innovation pipeline by introducing enhanced multiphoton microscopy platforms designed for deep tissue imaging, significantly improving neuroscience and oncology research capabilities.
- January 2026: Thermo Fisher Scientific expanded its advanced bioimaging portfolio by integrating AI-powered fluorescence microscopy tools aimed at improving cellular-level analysis in cancer and gene therapy research, enhancing precision in biophotonics-based diagnostics.
- December 2025: Danaher Corporation (through Leica Microsystems) introduced next-generation confocal microscopy systems with enhanced real-time imaging capabilities, supporting high-resolution live-cell imaging for biomedical and clinical research applications.
- November 2025: Hamamatsu Photonics announced development of high-sensitivity photodetectors and optical sensors tailored for medical imaging and spectroscopy applications, strengthening its role in next-generation biophotonics diagnostics.
- October 2025: PerkinElmer launched upgraded optical imaging solutions for in-vitro diagnostics, focusing on biophotonics-enabled detection technologies to improve early disease screening and biomarker identification.
